| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| ROR2 | HOTAvitag RO2-H82E3 | Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $495.00 25ug | ||
| ROR2 | HOT RO2-H5251 | Human ROR2 / NTRKR2 Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $300.00 50ug | ||
| ROR2 | HOT RO2-H52E5 | Human ROR2 / NTRKR2 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $380.00 50ug | ||
| ROR2 | Cynomolgus ROR2 / NTRKR2 Protein, His Tag (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $310.00 100ug | |||
| ROR2 | Mouse ROR2 / NTRKR2 Protein, Fc Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $465.00 100ug | |||
| ROR2 | Mouse ROR2 / NTRKR2 Protein, His Tag (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $465.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ozuriftamab Vedotin | HTBA-3021; CAB-ROR2; CAB-ROR2-ADC; CAB-ADC; BA-3021 | Phase 2 Clinical | Bioatla | Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | Details |